Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry
Results 8441 - 500 out of 500 displayed.
« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Reset ↻

Asep Medical's Sepsis Diagnostic Technology Can Provide Improved Odds for Pediatric Appendicitis

Read more ››

By: PR Newswire Association LLC. - 28 Feb 2024

Aclarion Announces Closing of $3.0 Million Public Offering

Read more ››

By: GlobeNewswire - 27 Feb 2024

Related companies: Aclarion

Capital Increase in Genmab as a Result of Employee Warrant Exercise

Read more ››

By: GlobeNewswire - 27 Feb 2024

Related companies: Genmab A/S

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

Read more ››

By: GlobeNewswire - 27 Feb 2024

Related companies: Genmab A/S

BioAegis Therapeutics Unveils Upcoming Clinical Study of Gelsolin, an Immune Regulator, as a Treatment for Patients with Acute Respiratory Distress Syndrome (ARDS)

Read more ››

By: GlobeNewswire - 27 Feb 2024

Related companies: BioAegis Therapeutics Inc.

Cytokinetics Reports Fourth Quarter 2023 Financial Results

Read more ››

By: GlobeNewswire - 27 Feb 2024

Related companies: Cytokinetics, Inc.

Vaxcyte Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Read more ››

By: GlobeNewswire - 27 Feb 2024

Related companies: Vaxcyte, Inc.

Kura Oncology Reports Fourth Quarter and Full Year 2023 Financial Results

Read more ››

By: GlobeNewswire - 27 Feb 2024

Related companies: Kura Oncology, Inc.

Ventyx Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Corporate Progress

Read more ››

By: GlobeNewswire - 27 Feb 2024

Related companies: Ventyx Biosciences, Inc.

Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024

Read more ››

By: GlobeNewswire - 27 Feb 2024

Related companies: Anika Therapeutics, Inc.

Progyny, Inc. Announces Fourth Quarter 2023 Results

Read more ››

By: GlobeNewswire - 27 Feb 2024

Related companies: Progyny, Inc.

PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2023 Results

Read more ››

By: GlobeNewswire - 27 Feb 2024

Related companies: PROCEPT BioRobotics Corporation

Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2023 Financial Results

Read more ››

By: GlobeNewswire - 27 Feb 2024

Related companies: Pliant Therapeutics, Inc.

OraSure Reports Q4 ‘23 Revenue of $75.9 Million

Read more ››

By: GlobeNewswire - 27 Feb 2024

Related companies: OraSure Technologies, Inc.

RadNet to Enter the Houston, Texas Market through Platform Acquisition of Houston Medical Imaging

Read more ››

By: GlobeNewswire - 27 Feb 2024

Related companies: RadNet, Inc

OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial Results

Read more ››

By: GlobeNewswire - 27 Feb 2024

Related companies: OPKO Health, Inc.

ICU Medical Announces Fourth Quarter 2023 Results and Provides Fiscal Year 2024 Guidance

Read more ››

By: GlobeNewswire - 27 Feb 2024

Related companies: ICU Medical, Inc.

ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023

Read more ››

By: GlobeNewswire - 27 Feb 2024

Related companies: ImmuCell Corporation

Kronos Bio Announces Participation in 44th Annual Cowen Health Care Conference

Read more ››

By: GlobeNewswire - 27 Feb 2024

Related companies: Kronos Bio, Inc.

Myriad Genetics Reports Strong Fourth Quarter and Full-Year 2023 Financial Results; Fourth Quarter Revenue of $197 Million and Full-Year Revenue of $753 Million Each Grew 11% Year-Over-Year; Delivered GAAP EPS of $(0.36) and Adjusted EPS of $0.04 in

Read more ››

By: GlobeNewswire - 27 Feb 2024

Related companies: Myriad Genetics, Inc.

« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

to the top ↑